Login
$SEPN
$41.67 -$0.93 (2.18%) Live

Company Executives

Officer Age In this role 2025 pay Source
Jeffrey Finer Also a director
Chief Executive Officer
Title from the Form 4 dated Nov 12, 2026
60 Not stated $2,933,339
Gil M. Labrucherie
Chief Financial Officer
54 Not stated $3,240,351
Liz Bhatt
President and Chief Operating Officer
58 Not stated $1,590,770
Elizabeth Bhatt
President and COO
Title from the Form 4 dated Oct 15, 2026
Not stated Not stated Not reported
Jae B. Kim
Chief Medical Officer
56 Since 2024
2 years
Not reported
Samira Shaikhly
Chief People Officer
56 Since 2023
3 years
Not reported
Mark Wilson
Chief Legal Officer
55 Since 2026
this year
Not reported
Rajiv Patni
Chief Medical Officer
Title from the Form 4 dated Sep 8, 2026
Not stated Not stated Not reported
Uwe Klein
Senior Vice President, Biological Sciences
61 Since 2021
5 years
Not reported
Daniel Long
Senior Vice President, Drug Discovery
53 Since 2021
5 years
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
6 of 8
stated in the proxy
Average tenure
3.8 years
from year joined
CEO also chairs the board
No
Jeffrey Tong
Director Age On board Independent Committees Other public boards Pay Source
Jeffrey Tong
51 2019
7 years
Independent
Nominating and Corporate Governance Committee
None stated Not stated
Jeffrey Finer
60 2021
5 years
Not independent None stated None stated Paid as CEO
Shalini Sharp
51 2024
2 years
Independent
Audit Committee · Chair
BeOne Medicines Ltd. Not stated
Jake Simson
40 2023
3 years
Independent
Audit Committee
Bicara Therapeutics Inc. Not stated
Bernard Coulie
60 2023
3 years
Independent
Research and Development Committee
None stated Not stated
Abraham Bassan
41 2021
5 years
Independent None stated Rani Therapeutics Holdings, Inc. Not stated
Alan Ezekowitz
72 2022
4 years
Not independent
Research and Development Committee
Fulcrum Therapeutics, Inc. Not stated
Keith Gottesdiener
72 2025
1 year
Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support